EGP-437

EyeGate Receives Milestone Payment for Completion of Enrollment in Ph III Study in Anterior Uveitis
CP Wire
Fri, 04/6/18 - 09:47 am
EyeGate Pharma
clinical trials
EGP-437
non-infectious anterior uveitis
Valeant Pharmaceuticals
EyeGate Receives Milestone Payment for Completion of Enrollment in Ph III Study in Anterior Uveitis
Sun, 04/8/18 - 01:00 pm
EyeGate Pharma
EGP-437
uveitis
EyeGate Pharma Receives Orphan Drug Designation for Corneal Graft Rejection From U.S. FDA
MSNBC
Sat, 01/10/09 - 12:37 pm
EyeGate Pharma
EGP-437
dexamethasone phosphate